Versed News and Research

RSS

Versed is a drug used to treat anxiety and tension and to relax muscles. It is also being studied in the treatment of nausea and vomiting caused by some cancer treatments. It is a type of benzodiazepine. Also called midazolam and midazolam hydrochloride.

Roundup: Feds cut N.Y. Medicaid payments $1.2B; 93,000 fewer kids enroll in CHIP in Pa.; W. Va. lawmakers promise miners benefits

Federal authorities have dramatically lowered the amount that New York state can claim from the federal government for certain medical services, costing the state an estimated $1.2 billion.

3 Apr 2013

Forty percent of vets have little understanding of benefits due them

More than half of America's veterans say they have little or no understanding of the benefits due them, despite efforts over recent years to match returning soldiers with the help and services they need. An analysis of Department of Veterans Affairs survey data found that younger veterans – those who served in the post-9/11 war period – are better versed in their benefits.

21 Nov 2012

Michigan State University to improve food security and nutrition in Africa and Asia

Michigan State University will use a $7.3 million federal grant to cultivate the next generation of agricultural scientists in Africa and Asia, in hopes of improving food security and nutrition there.

7 Aug 2012

Longer looks: Alzheimer's researcher turns to drug she helped invent

Given her relatively young age, Dr. Rae Lyn Burke didn't think much about her family history of Alzheimer's disease -- a grandmother and an aunt had suffered from it, but they were much older. Ironically, Burke was just in her late 50s when she started having her own symptoms of early onset Alzheimer's. Even more ironic is that Burke had been one of the key developers of the Alzheimer's drug bapineuzumab, which she now takes herself to reduce the progression of the disease in her own brain.

22 Jun 2012

C-section rates in US stabilize after eight years of steady increase

A new report on trends in women's health in the United States reveals the national C-section rate has held steady at 33 percent since 2009, leveling off after eight years of steady increase that was in part driven by scheduled, elective surgeries and a trend for increasing the repeat C-section.

19 Jun 2012

Football-related brain injuries appear to rise among high school students

Catastrophic brain injuries associated with full-contact football appear to be rising, especially among high school students, according to a new report.

17 Apr 2012

News briefs from featured presentations at Cardiology 2012

Pediatric cardiology researchers and clinicians from almost 50 centers from across the U.S. and around the world are gathering at the Cardiology 2012 Conference sponsored by The Children's Hospital of Philadelphia on Feb. 22-26 in Orlando, Fla.

27 Feb 2012

Autism Speaks releases two new ATN tool kits

Autism Speaks, North America's leading autism science and advocacy organization, today released the Sleep Strategies for Children with Autism: A Parent's Guide and Treating Children with Autism Spectrum Disorders: A Tool Kit for Dental Professionals, both available for free download on Autism Speaks Tools You Can Use webpage.

22 Feb 2012

African-American children tend to be diagnosed later for autism

The rate of diagnosis for autism spectrum disorders (ASD) is the same among all racial groups — one in 110, according to current estimates. However, a study by a Florida State University researcher has found that African-American children tend to be diagnosed later than white children, which results in a longer and more intensive intervention.

16 Feb 2012

Gilead, Bristol-Myers Squibb to develop and commercialize fixed-dose combination for HIV

Bristol-Myers Squibb Company and Gilead Sciences, Inc. today announced a licensing agreement for Bristol-Myers Squibb to develop and commercialize a fixed-dose combination containing Bristol-Myers Squibb's protease inhibitor REYATAZ (atazanavir sulfate) and Gilead's cobicistat, a pharmacoenhancing or "boosting" agent that increases blood levels of certain HIV medicines to potentially allow for one pill once daily dosing.

27 Oct 2011

Dallas Children's administrator speaks at Chicago healthcare conference

Nationally acclaimed Studer Group, a private health care consulting firm, has chosen David Biggerstaff, vice president and administrator of Dallas Children's Medical Center at Legacy, to lead a comprehensive session at its ninth annual "What's Right in Health Care" conference in Chicago, Oct. 19 through 21.

20 Oct 2011

JU launches new curriculum for online RN to BSN degree program

Registered nurses choosing to complete a bachelor's degree need a program that prepares them to take leadership roles within their organizations. To address this need, U.S.News & World Report-ranked Jacksonville University (JU) is launching a new curriculum for its online RN to BSN degree program.

1 Oct 2011

Converting genetic data into biomedical knowledge a true challenge for statisticians

Within a decade, a combination of advanced measurement techniques and statistics will enable scientists to develop methods to diagnose serious diseases caused by genetic defects. Ten years after that, there may be medicines available to repair these defects.

21 Sep 2011

UT Southwestern surgeons to perform first hand transplant in North Texas

A team of surgeons at UT Southwestern Medical Center expects to perform the first hand transplant in North Texas within a year, making the institution just the sixth hospital in the U.S. to perform the rare and intricate surgery.

30 Aug 2011

Merck's VICTRELIS receives European CHMP positive opinion for treatment of chronic HCV genotype 1 infection

Merck, today announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a positive opinion under accelerated assessment recommending approval of the investigational medicine VICTRELIS (boceprevir) for the treatment of chronic hepatitis C virus genotype 1 infection, in combination with peginterferon alfa and ribavirin, in adult patients with compensated liver disease who are previously untreated or who have failed previous therapy.

20 May 2011

JumpStart Ventures invests $250,000 in SPR Therapeutics

JumpStart Ventures, a nonprofit that invests in and partners with innovative, early-stage companies in Northeast Ohio, announced an investment commitment of $250,000 in SPR Therapeutics.

27 Apr 2011

QHR signs agreement to acquire EMIS assets

QHR Technologies Inc. today announced that the Company has signed an Asset Purchase Agreement ("APA") to acquire the assets of EMIS Inc. a 100% subsidiary of Egton Medical Information Systems Limited based in Leeds, UK and part of EMIS Group plc.

27 Apr 2011

Ashford University introduces Bachelor of Arts in Health Education degree

Ashford University, an academic institution owned by Bridgepoint Education, has just introduced its Bachelor of Arts in Health Education degree. This program is positioned to support students seeking employment in the ever-expanding health care industry.

18 Feb 2011

Pediatric physicians present 12 research abstracts, posters at Cardiology 2011

Pediatric cardiology researchers and clinicians gather this week in Scottsdale, Ariz. for Cardiology 2011, the 15th Annual Update on Pediatric and Congenital Cardiovascular Disease, sponsored by The Children's Hospital of Philadelphia. Original research from more than 30 cardiac programs in the U.S. and abroad is being presented throughout the meeting.

7 Feb 2011

Key Equipment Finance and Hitachi Medical Systems America enter new partnership

Key Equipment Finance, one of the nation's largest bank-held equipment finance companies and an affiliate of KeyCorp today announced that the company has entered into an exclusive, long term, program agreement with Hitachi Medical Systems America. Hitachi Medical Systems America is the U.S. distributor of Hitachi Medical Corporation's diagnostic imaging products.

10 Jan 2011